Vidhi Specialty Food Ingredients Limited – Investor Presentation Summary

Key Operational Highlights

  • Total manufacturing capacity of ~7,500 MT per annum with ~4,200 MT per annum under expansion.
  • Exporting to over 80 countries across 6 continents, holding a Two-Star Export House status.
  • Three production facilities in Dhatav Village, Raigad District, Maharashtra, spread over 1,76,000 square feet.
  • Two dedicated R&D facilities in Rabale with a team of PhDs and chemists for new product development.
  • Key drivers include a favorable product portfolio mix, higher sales of cosmetic dyes, and value-added products.

Segment-wise Performance

Not Specified

Financial Highlights

Q1 FY27 Consolidated (Rs. in Crores)

  • Revenue from Operations: ₹146.3
  • EBITDA: ₹26.0
  • PAT: ₹17.1
  • EPS: ₹3.4
  • Gross Profit Margin: 33.6%
  • EBITDA Margin: 17.8%
  • PAT Margin: 11.7%

YoY Comparison (Q1 FY27 vs Q1 FY26)

  • Revenue Growth: 66.4%
  • Gross Profit Growth: 29.1%
  • EBITDA Growth: 26.7%
  • PAT Growth: 34.7%

QoQ Comparison (Q1 FY27 vs Q4 FY26)

  • Revenue Growth: 19.2%
  • Gross Profit Growth: 4.2%
  • EBITDA Growth: 26.1%
  • PAT Growth: 30.2%

Drivers of financial performance: Favourable product portfolio mix and higher sales of cosmetic dyes and other value-added products, contributing to an EBITDA margin expansion of approximately 400 basis points.

Key Risks: Not explicitly disclosed in the presentation.

Geographical Revenue Split

  • Top 10 countries contribute ~80.81% of revenues in Q1 FY27.
  • Top 10 customers contribute ~69.88% of revenues in Q1 FY27.
  • Domestic vs Export split: Not Specified

Balance Sheet Snapshot (as of Mar-26, Rs. in Cr)

  • Total Equity: ₹327.8
  • Total Assets: ₹418.6
  • Inventories: ₹80.8
  • Trade Receivables: ₹143.0
  • Cash and Cash Equivalents: ₹11.5
  • Other Bank Balances: ₹8.4
  • Financial Liabilities (Borrowings): ₹56.5 (Current), ₹0.0 (Non-Current)
  • Net Debt/Equity: Not Specified

Financial Health Insights: Strong revenue growth and profitability improvement; healthy trade receivables and inventory levels.

Capex & Cash Flow Health

  • Net Cash from Operating Activities (FY26): ₹42.4 Cr
  • Cash Flow from Investing Activities (FY26): (₹15.5) Cr
  • Cash Flow from Financing Activities (FY26): (₹35.2) Cr
  • Capital Expenditure: Two strategic expansion projects underway (Project 1: 200 MT/month, Project 2: 300 MT/month).

Investment Rationale: Focus on capacity expansion into high-growth application areas (pharma coatings, cosmetics, plastics, inks).

Strategic & R&D Initiatives

Project 1 (Arjun Foods, Roha)

  • Key application: Pharma and healthcare (tablet coatings).
  • Capacity: Planned 200 MT per month in 2 phases.
  • Update: Pilot plant ready; product under sampling with marquee companies.

Project 2 (Dahej)

  • Key applications: Cosmetics & Personal Care, Plastics, Paints, Inks, Automotive, Packaging, Textiles, Construction, Stationery, Security, Electronics.
  • Capacity: Planned 300 MT per month in 2 phases.
  • Update: Pilot plant ready; product sampling to begin soon.

Expected impact on growth: To generate meaningful new revenue streams over the coming years and transform the company into an innovation-led, solutions-driven partner.

Strategic Rationale: Expanding into high-growth, high-margin application areas beyond traditional food colors.

Industry Trends & Business Environment

  • The India food colorants market is expected to grow from USD 210.98 million in 2026 to USD 311.69 million by 2031 at an 8.12% CAGR.
  • Growth drivers: Diversified end-user application, economic viability vs. natural colors, growing demand in emerging markets.
  • Impact on Company: Positions Vidhi to benefit from market growth with its expanded product portfolio and capacity.

Management Commentary & Growth Outlook

Strategic Outlook: "We are entering an exciting new chapter where multiple growth engines are coming together to create significant long-term opportunities for the Company." The expansion into tablet coatings and specialty products opens new avenues across industries and geographies.

FY Guidance: Not explicitly provided. The outlook is positive based on strategic expansion projects and a favorable product mix.

Risks and Opportunities: The transformational journey involves investing in future-ready platforms and expanding innovation capabilities. The company is well-positioned for its next era of growth and value creation.